Jl. Ho et al., STRUCTURE-FUNCTION ANALYSIS OF LEISHMANIA LIPOPHOSPHOGLYCAN - DISTINCT DOMAINS THAT MEDIATE BINDING AND INHIBITION OF ENDOTHELIAL-CELL FUNCTION, The Journal of immunology, 157(7), 1996, pp. 3013-3020
We have shown that Leishmania lipophosphoglycan (LPG) inhibits IL-1 be
ta gene expression in human monocytes. Here, we show that LPC can bind
in a time-dependent manner and suppress endothelial cell activation,
possibly via specific LPG domains. Endotoxin (10 ng/ml, 4 h) consisten
tly caused endothelium to increase monocyte adhesion (similar to 20-fo
ld). LPC pretreatment (2 mu M, 2 h) completely blocked endotoxin-media
ted monocyte adhesion. LPG did not grossly suppress endothelial functi
ons because TNF-alpha- and IL-1 beta-mediated adhesion toward monocyte
s were not affected. Using four highly purified LPC fragments (namely,
repeating phosphodisaccharide (PGM), phosphoglycan, phosphosaccharide
core-lyso-alkyl-phosphatidylinositol (core-PI), and lyso-alkyl-phosph
atidylinositol (lyse-PI)), we examined whether these fragments can ind
ependently inhibit endothelial adhesion. In contrast to that of intact
LPG, neither the four LPG fragments (2 mu M, 2 h) independently nor t
he co-addition of phosphoglycan and core-PI fragments blocked the endo
toxin-mediated adhesion to monocytes. To determine whether the fragmen
ts can reverse the effect of intact LPC, endothelial cells were first
pretreated with the LPC fragments (10 mu M, 15 min), followed by the a
ddition of LPG (2 mu M). All four LPC fragments fully reversed the eff
ect of LPG. Simultaneous addition of LPC fragments and intact LPC caus
ed only partial suppression (similar to 45%), while the addition of LP
C fragments 15 min later had no reversal effect. Flow cytometry reveal
ed that only core-PI and lyse-PI competitively inhibited (similar to 3
0%) LPC binding. Conversely, LPC competed with the binding of [H-3]lys
o-PJ (similar to 30%). Furthermore, mAb against the PGM reversed (simi
lar to 70%) the effect of LPC. Thus, the lyso-PI domain on LPC mediate
s binding to endothelial cells, whereas the PGM domain mediates the ce
ll inhibitory effect.